NOBI-VAC REO
NOBI-VAC REO
Authorised
- REOVIRUS
Product identification
Medicine name:
NOBI-VAC REO
Active substance:
- REOVIRUS
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
REOVIRUS7.40/log2 enzyme-linked immunosorbent assay unit(s)0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- 14162
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 25/08/2022